MTC MISSION supports multidisciplinary research teams working on sector-led translational research to advance Singapore’s priorities and bring technologies into industry use with commercial impact.
Drug Development RFP supports researchers and clinicians developing drugs and devices through IND-enabling studies and early clinical trials to advance treatments for Alzheimer’s disease and related dementias.
Cancer Research UK's CDD supports the development of novel cancer agents from preclinical stages to early clinical trials with expert resources, not monetary funding.
Therapeutic Catalyst supports academic researchers in early drug discovery, funding target identification, validation and early antibody or small molecule development to advance treatments for adult cancers.
Drug Discovery Postdoctoral Fellowship supports postdoctoral researchers’ multidisciplinary training and early-stage drug discovery to advance safe, effective treatments with potential for human translation.